DNA topoisomerases in apicomplexan parasites: Promising targets for drug discovery

Proceedings of the Royal Society B: Biological Sciences

Volumn 277, Issue 1689, 2010, Pages 1777-1787

  García Estrada, Carlos ^a   Prada, Christopher Fernández ^a   Fernández Rubio, Celia ^a   Rojo Vázquez, Francisco ^a   Balaña Fouce, Rafael ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

Apicomplexan protozoa; Chemotherapy; Dna topoisomerases; Tropical diseases

Indexed keywords

ABORTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHEMOTHERAPY; DIARRHEAL DISEASE; DISEASE VECTOR; DRUG DEVELOPMENT; DRUG RESISTANCE; ENDOSYMBIONT; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; MALARIA; MITOCHONDRIAL DNA; PARASITE; PATHOGEN; PROTOZOAN; VACCINE;

ANIMALIA; APICOMPLEXA; BACTERIA (MICROORGANISMS); CRYPTOSPORIDIUM PARVUM; EUKARYOTA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROKARYOTA; PROTOZOA; TOXOPLASMA GONDII;

EID: 77954320167     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2009.2176     Document Type: Conference Paper

References (98)

1. Anonymous 2000 DNA topoisomerase II inhibitors. IARC Monogr. Eval. Carcinog. Risks Hum. 76, 175-344.
2. Aravind, L., Leipe, D. D. & Koonin, E. V. 1998 Toprim: a conserved catalytic domain in type IA and II topoisomerases, DNAG-type primases, OLD family nucleases and RecR proteins. Nucleic Acids Res. 26, 4205-4213. (doi:10.1093/nar/26.18.4205)
3. Auparakkitanon, S. & Wilairat, P. 2000 Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in malaria parasite, Plasmodium falciparum. Biochem. Biophys. Res. Commun. 269, 406-409. (doi:10.1006/ bbrc.2000.2305)
4. Balana-Fouce, R., Redondo, C. M., Perez-Pertejo, Y., DiazGonzalez, R. & Reguera, R. M. 2006 Targeting atypical trypanosomatid DNA topoisomerase I. Drug Discov. Today 11, 733-740. (doi:10.1016/j.drudis.2006.06.014)
5. Bates, A. D. & Maxwell, A. 2007 Energy coupling in type II topoisomerases: why do they hydrolyze ATP? Biochemistry 46, 7929-7941. (doi:10.1021/bi700789g)
6. Berger, J. M., Gamblin, S. J., Harrison, S. C. & Wang, J. C. 1996 Structure and mechanism of DNA topoisomerase II. Nature 379, 225-232. (doi:10.1038/379225a0)
7. Bergerat, A., Gadelle, D. & Forterre, P. 1994 Purification of a DNA topoisomerase II from the hyperthermophilic archaeon Sulfolobus shibatae. A thermostable enzyme with both bacterial and eukaryal features. J. Biol. Chem. 269, 27 663-27 669.
8. Bjergbaek, L., Kingma, P., Nielsen, I. S., Wang, I., Westergaard, O., Osheroff, N. & Andersen, A. M. 2000 Communication between the ATPase and cleavage/religation domains of human topoisomerase IIa. J. Biol Chem. 275, 13 041-13 048. (doi:10.1074/jbc.275.17.13041)
9. Bodley, A. L., Cumming, J. N. & Shapiro, T. A. 1998 Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum. Biochem. Pharmacol. 55, 709-711. (doi:10.1016/S0006-2952(97)00556-X)
10. Bodley, A. L., Chakraborty, A. K., Xie, S., Burri, C. & Shapiro, T. A. 2003 An unusual type IB topoisomerase from African trypanosomes. Proc. Natl Acad. Sci. USA 100, 7539-7544. (doi:10.1073/pnas.1330762100)
11. Broccoli, S. J., Marquis, F., Papadopoulou, B., Olivier, M. & Drolet, M. 1999 Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase. Nucleic Adds Res. 27, 2745-2752. (doi:10.1093/nar/27.13.2745)
12. Burri, C., Bodley, A. L. & Shapiro, T. A. 1996 Topoisomerases in kinetoplastids. Parasitol. Today 12, 226-231. (doi:10.1016/0169-4758(96)10017-X)
13. Carter, R. & Mendis, K. N. 2002 Evolutionary and historical aspects of the burden of malaria. Clin. Microbiol. Rev. 15, 564-594. (doi: 10.1128/CMR. 15.4.564-594.2002)
14. Champoux, J. J. 1998 Domains of human topoisomerase I and associated functions. Prog. Nucleic Acids Res. Mol. Biol. 60, 111-132. (doi:10.1016/S0079- 6603(08) 60891-0)
15. Champoux, J. J. 2001 DNA Topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70, 369-413. (doi: 10.1146/annurev.biochem.70.1. 369)
16. Chappell, C. L. & Okhuysen, P. C. 2002 Cryptosporidiosis. Curr. Opin. Infect Dis. 15, 523-527.
17. Chavalitshewinkoon, P., Wilairat, P., Gamage, S., Denny, W., Figgitt, D. & Ralph, R. 1993 Structure-activity relationships and mode of action of 9-anilino acridines against chloroquine-resistant Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 37, 403-406.
18. Chavalitshewinkoon, P., Leelaphiwat, S. & Wilairat, P. 1994 Partial purification and characterization of DNA topoisomerase II from Plasmodium falciparum. Southeast Asian J. Trop. Med. Public Health 25, 32-36.
19. Chavalitshewinkoon, P., Worasing, R. & Wilairat, P. 2001 Partial purification and characterization of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors. Southeast Asian J. Trop. Med. Public Health 32, 733-738.
20. Cheesman, S. J. 2000 The topoisomerases of protozoan parasites. Parasitol. Today 16, 277-281. (doi:10.1016/ S0169-4758(00)01697-5)
21. Cheesman, S., McAleese, S., Goman, M., Johnson, D., Horrocks, P., Ridley, R. G. & Kilbey, B. J. 1994 The gene encoding topoisomerase II from Plasmodium falciparum. Nucleic Acids Res. 22, 2547-2551. (doi: 10. 1093/nar/22.13.2547)
22. Christopher, L. J. & Dykstra, C. C. 1994 Identification of a type II topoisomerase gene from Cryptosporidium parvum. J. Eukaryot. Microbiol. 41, 28S.
23. Commodaro, A. G., Belfort, R. N., Rizzo, L. V., Muccioli, C., Silveira, C., Burnier, M. N. & Belfort Jr, R. 2009 Ocular toxoplasmosis: an update and review of the literature. Mem. Inst. Oswaldo Cruz 104, 345-350. (doi: 10. 1590/S0074-02762009000200030)
24. Corbett, K. & Berger, J. M. 2004 Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. Annu. Rev. Biophys. Biomol. Struct. 33, 95-118. (doi:10.1146/annurev.biophys.33.110502. 140357)
25. Costa da Silva, R. & Longoni, H. 2009 Toxoplasma gondii: host-parasite interaction and behaviour manipulation. Parasitol. Res. 105, 893-898. (doi: 10.1007/S00436-0091526-6)
26. Crick, F. H. 1976 Linking number and chromosomes. Proc. Natl Acad. Sci. USA 73, 2639-2643. (doi:10.1073/pnas. 73.8.2639)
27. Cunningham, D., Pyrhonen, S. & James, R. D. 1998 Randomised trial of irinotecan plus supportive care versus supportive care alone after Fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352, 1413-1418. (doi:10.1016/S0140-6736(98)02309-5)
28. D'Arpa, P., Machlin, P. S., Ratrie, H. D., Rothfield, N. F., Cleveland, D. W & Earnshaw, W. C. 1988 cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc. Natl Acad. Sci. USA 85, 2543-2547. (doi:10.1073/pnas.85.8.2543)
29. Dahl, E. L. & Rosenthal, P. J. 2007 Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob. Agents Chemother. 51, 3485-3490. (doi: 10.1128/AAC.00527-07)
30. Dahl, E. L. & Rosenthal, P. J. 2008 Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. Trends Parasitol. 24, 279-284. (doi: 10. 1016/j.pt.2008.03.007)
31. Dar, M. A., Sharma, A., Mondal, N. & Dhar, S. K. 2007 Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit. Eukaryot. Cell 6, 398-412. (doi:10.1128/EC. 00357-06)
32. Divo, A. A., Sartorelli, A. C., Patton, C. L. & Bia, F. J. 1988 Activity of fluoroquinolone antibiotics against Plasmodiumfalciparum in vitro. Antimicrob. Agents Chemother. 32, 1182-1186.
33. Dorny, P., Praet, N., Deckers, N. & Gabriel, S. 2009 Emerging food-borne parasites. Vet. Parasitol. 163, 196-206. (doi:10.1016/j.vetpar.2009. 05.026)
34. Drlica, K. 1999 Mechanism of fluoroquinolone action. Curr. Opin. Microbiol. 2, 504-508. (doi:10.1016/S1369-5274(99)00008-9)
35. Eastman, R. T. & Fidock, D. A. 2009 Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat. Rev. Microbiol. 7, 864-874. (doi: 10.1038/ nrmicro2239)
36. Fayer, R. 2004 Cryptosporidium: a water-borne zoonotic parasite. Vet. Parasitol. 126, 37-56. (doi: 10. 1016/j.vetpar.2004.09.004doi:10.1016/j.vetpar. 2004.09. 004)
37. Fichera, M. E. & Roos, D. S. 1997 A plastid organelle as a drug target in apicomplexan parasites. Nature 390, 407-409. (doi:10.1038/37132doi:10. 1038/37132)
38. Fleige, T. & Soldati-Favre, D. 2008 Targeting the transcriptional and translational machinery of the endosymbiotic organelle in apicomplexans. Curr. Drug Targets 9, 948-956. (doi:10.2174/138945008786786073)
39. Forterre, P., Gribaldo, S., Gadelle, D. & Serre, M. C. 2007 Origin and evolution of DNA topoisomerases. Biochimie 89, 427-446. (doi:10.1016/j. biochi.2006.12.009)
40. Fu, S. & Xiao, S. H. 1991 Pyronaridine: a new antimalarial drug. Parasitol. Today 7, 310-313. (doi: 10.1016/0169-4758(91)90267-R)
41. Goodman, C. D., Su, V. & McFadden, G. I. 2007 The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem. Parasitol. 152, 181-191. (doi:10.1016/j.molbiopara.2007.01.005)
42. Harb, O. S., Chatterjee, B., Fraunholz, M. J., Crawford, M. J., Nishi, M. & Roos, D. S. 2004 Multiple functionally redundant signals mediate targeting to the apicoplast in the apicomplexan parasite Toxoplasma gondii. Eukaryot. Cell 3, 663-674. (doi:10.1128/EC.3.3. 663-674.2004)
43. Iaccheri, B., Papadaki, T., Androudi, S., Janjua, S., Bhaila, I. & Stephen Foster, C. 2008 Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review. Clin. Ther. 30, 2069-2074. (doi:10.1016/j.clinthera. 2008.10.021)
44. Jensen, A. D. & Svejstrup, J. Q. 1996 Purification and characterization of human topoisomerase I mutants. Eur. J. Biochem. 236, 389-394. (doi:10.1111/j.1432-1033.1996.00389.x)
45. Kelly, J. M., McRobert, L. & Baker, D. A. 2006 Evidence on the chromosomal location of centromeric DNA in Plasmodium falciparum from etoposide-mediated topoisomeraseII cleavage. Proc. Natl Acad Sci. USA 103, 6706-6711. (doi: 10.1073/pnas.0510363103)
46. Khan, A. A., Slifer, T, Araujo, F. G. & Remington, J. S. 1996 Trovafloxacin is active against Toxoplasma gondii. Antimicrob. Agents Chemother. 40, 1855-1859.
47. Khor, V., Yowell, C., Dame, J. B. & Rowe, T. C. 2005 Expression and characterization of the ATP-binding domain of a malarial Plasmodium vivax gene homologous to the B-subunit of the bacterial topoisomerase DNA gyrase. Mol. Biochem. Parasitol. 140, 107-117. (doi:10. 1016/j.molbiopara.2004.12.013)
48. Kosek, M., Alcantara, C., Lima, A. A. & Guerrant, R. L. 2001 Cryptosporidiosis: an update. Lancet Infect. Dis. 1, 262-269. (doi:10.1016/S1473-3099(01)00121-9)
49. Krause, P. J. 2003 Babesiosis; diagnosis and treatment. Vector-Borne Zoonotic Dis. 3, 45-51. (doi:10.1089/ 153036603765627451)
50. Louie, A. C. & Issell, B. F. 1985 Amsacrine (AMSA): a clinical review. J. Clin. Oncol. 3, 562-592.
51. McFadden, G. I. & Roos, D. S. 1999 Apicomplexan plastids as drug targets. Trends Microbiol. 7, 328-333. (doi:10. 1016/S0966-842X(99)01547-4)
52. Mead, J. R. 2002 Cryptosporidiosis and the challenges of chemotherapy. Drug Resist. Updat. 5, 47-57. (doi:10. 1016/S1368-7646(02)00011-0)
53. Meslin, B., Barnadas, C., Boni, V., Latour, C., De Monbrison, F., Kaiser, K. & Picot, S. 2007 Features of apoptosis in Plasmodium falciparum erythrocytic stage through a putative role of PfMCA1 metacaspase-like protein. J. Infect Dis. 195, 1852-1859. (doi:10.1086/ 518253)
54. Mita, T., Tanabe, K. & Kita, K. 2009 Spread and evolution of Plasmodium falciparum drug resistance. Parasitol. Int. 58, 201-209. (doi:10.1016/j.parint.2009.04.004)
55. Mo, Y. Y., Wang, C. & Beck, W. T. 2000 A novel nuclear localization signal in human DNA topoisomerase I. J. Biol. Chem. 275, 41107-41113. (doi:10.1074/jbc. M003135200)
56. Morrison, D. A. 2009 Evolution of the Apicomplexa. Where are we now? Trends Parasitol. 25, 375-382. (doi:10.1016/j. pt.2009.05.010)
57. Mosier, D. A. & Oberst, R. D. 2000 Cryptosporidiosis. A global challenge. Ann. NY Acad. Sci 916, 102-111. (doi: 10.1111/j. 1749-6632.2000. tb05279.x)
58. Ordonez, C., Balaña-Fouce, R., Ordonez, D. & Alfonso, J. 2009 Functional expression of a DNA-topoisomerase IB from Cryptosporidium parvum. J. Biomed. Biotech. 2009, 837608. (doi: 10.1155/2009/837608)
59. Peter, B. J., Ullsperger, C., Hiasa, H., Marians, K. J. & Cozzarelli, N. R. 1998 The structure of supercoiled intermediates in DNA replication. Cell 94, 819-827. (doi:10. 1016/S0092-8674(00)81740-7)
60. Pizzolato, J. F. & Saltz, D. B. 2003 The camptomecins. Lancet 361, 2235-2242. (doi:10.1016/S0140-6736(03) 13780-4)
61. Pommier, Y. 2006 Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev. Cancer 6, 789-802. (doi:10. 1038/nrc1977)
62. Pommier, Y et al. 2003 Repair of and checkpoint response to topoisomerase I-mediated DNA damage. Mutat. Res. 532, 173-203. (doi:10.1016/j.mrfmmm.2003.08. 016)
63. Raghu Ram, E. V., Kumar, A., Biswas, S., Kumar, A., Chaubey, S., Siddiqi, M. I. & Habib, S. 2007 Nuclear gyrB encodes a functional subunit of the Plasmodium falciparum gyrase that is involved in apicoplast DNA replication. Mol. Biochem. Parasitol. 154, 30-39. (doi: 10.1016/ j.molbiopara.2007.04.001)
64. Ralph, S. A., Van Dooren, G. G., Waller, R. F., Crawford, M. J., Fraunholz, M. J., Foth, B. J., Tonkin, C. J., Roos, D. S. & McFadden, G. I. 2004 Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol. 2, 203-216. (doi: 10.1038/nrmicro843)
65. Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J. J. & Hoi, W. G. 1998 Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279, 1504-1513. (doi:10.1126/science.279.5356. 1504)
66. Redinbo, M. R., Champoux, J. J. & Hoi, W G. 2000 Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. Biochemistry 39, 6832-6840. (doi:10.1021/bi992690t)
67. Reece, R. J. & Maxwell, A. 1991 The C-terminal domain of the Escherichia coli DNA gyrase A subunit is a DNAbinding protein. Nucleic Acids Res. 19, 1399-1405. (doi:10.1093/nar/19.7.1399)
68. Reguera, R. M., Redondo, C. M., Gutierrez de Prado, R., Perez-Pertejo, Y. & Balana-Fouce, R. 2006 DNA topoisomerase I from parasitic protozoa: a potential target forchemotherapy. Biochim. Biophys. Acta 1759, 117-131. (doi:10.1016/j.bbaexp.2006.03.006)
69. Riou, J. F., Gabillot, M., Philippe, M., Schrevel, J. & Riou, G. 1986 Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. Biochemistry 25, 1471-1479. (doi:10. 1021/bi00355a001)
70. Santisteban, M. S. 1994 Structure of chromatin. I: levels of DNA organization in the nucleus; nucleosome and chromatin fibres. Pathol. Biol. (Paris) 42, 863-883.
71. Shuman, S. 1998 Vaccinia virus DNA topoisomerase: a model eukaryotic type IB enzyme. Biochim. Biophys. Acta 1400, 321-337. (doi: 10.1016/SO167-4781 (98) 00144-4)
72. Slesarev, A. I., Stetter, K. O., Lake, J. A., Geliert, M., Krah, R. & Kozyavkin, S. A. 1993 DNA topoisomerase V is a relative of eukaryotic topoisomerase I from a hyperthermophilic prokaryote. Nature 364, 735-737. (doi: 10. 1038/364735a0)
73. Stewart, L., Ireton, G. C. & Champoux, J. J. 1996 The domain organization of human topoisomerase I. J. Biol. Chem. 271, 7602-7608. (doi:i10.1074/jbc.271. 13.7602)
74. Stewart, L., Ireton, G. C. & Champoux, J. J. 1997 Reconstitution of human topoisomerase I by fragment complementation. J. Mol. Biol. 269, 355-372. (doi: 10. 1006/jmbi.l997.1056)
75. Stewart, L., Redinbo, M. R., Qiu, X., Hol, W. G. & Champoux, J. J. 1998 A model for the mechanism of human topoisomerase I. Science 279, 1534-1541. (doi:10.1126/science.279.5356.1534)
76. ten Bokkel Huinink, W. et al. 1997 Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J. Clin. Oncol. 15, 2183-2193.
77. Tenter, A. M., Heckeroth, A. R. & Weiss, L. 2000 Toxoplasma gondii: from animals to man. Int. J. Parasitol. 30, 1217-1258. (doi:10.1016/50020- 7519(00)00124-7)
78. Theodos, C. M., Griffims, J. K., D'Onfro, J., Fairfield, A. & Tzipori, S. 1998 Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob. Agents Chemother. 42, 1959-1965.
79. Tosh, K. & Kilbey, B. 1995 The gene encoding topoisomerase I from the human malaria parasite Plasmodium falciparum. Gene 163, 151-154. (doi:10.1016/0378-1119(95)00376-H)
80. Tosh, K., Cheesman, S., Horrocks, P. & Kilbey, B. 1999 Plasmodium faldparum: stage-related expression of topoisomerase I. Exp. Parasitol. 91, 126-132. (doi: 10.1006/ expr. 1998.4362)
81. Tzipori, S. & Widmer, G. A. 2008 A hundred-year retrospective on cryptosporidiosis. Trends Parasitol. 24, 184-189. (doi:10.1016/j.pt.2008.01.002)
82. Tzipori, S., Griffiths, J. & Theodos, C. 1995 Paromomycin treatment against cryptosporidiosis in patients with AIDS. J. Infect. Dis. 171, 1069-1070.
83. Vannier, E., Gewurz, B. E. & Krause, P. J. 2008 Human babesiosis. Infect. Dis. Clin. North Am. 22, 469-488. (doi:10.1016/j.idc.2008.03.010)
84. Villa, H. et al. 2003 A novel active DNA topoisomerase I in Leishmania donovani. J. Biol. Chem. 278, 3521-3526. (doi: 10.1074/jbc.M203991200)
85. Vologodskii, A. V. & Cozzarelli, N. R. 1994 Conformational and thermodynamic properties of supercoiled DNA. Annu. Rev. Biophys. Biomol. Struct. 23, 609-643. (doi:10.1146/annurev.bb.23.060194.003141)
86. Wall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. I. & Sim, G. A. 1966 Plant antitumour agents: the isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor fromCamptotheca accuminata. J. Am. Chem. Soc. 88, 3888-3890. (doi:10.1021/ja00968a057)
87. Wang, J. C. 1971 Interaction between DNA and an Escherichia coli protein omega. J. Mol. Biol. 55, 523-533. (doi:10.1016/0022-2836(71)90334-2)
88. Wang, J. C. 1996 DNA topoisomerases. Annu. Rev. Biochem. 65, 635-692. (doi:10.1146/annurev.bi.65.070196. 003223)
89. Wang, J. C. 2002 Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell. Biol. 3, 430-444. (doi:10.1038/nrm831)
90. Wei, H., Ruttenburg, A. J., Bechis, S. K. & Verdine, G. L. 2005 Nucleotide-dependent domain movement in the ATPase domain of human type IIA DNA topoisomerase. J. Biol. Chem. 280, 37041-37047. (doi:10.1074/jbc. M506520200)
91. Weiss, L. M., Wittner, M. L., Wasserman, S., Oz, H. S., Retsema, J. & Tanowitz, H. B. 1993 Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J. Infect Dis. 168, 1289-1292.
92. Weissig, V., Vetro-Widenhouse, T. S. & Rowe, T. C. 1997 Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasitePlasmodium falciparum. DNA Cell Biol. 16, 1483-1492. (doi:10.1089/dna.l997.16.1483)
93. White, J. H., Kilbey, B. J., de Vries, E., Goman, M., Alano, P., Cheesman, S., McAleese, S. & Ridley, R. G. 1993 The gene encoding DNA polymerase alpha from Plasmodium falciparum. Nucleic Acids Res. 21, 3643-3646. (doi: 10. 1093/nar/21.16.3643)
94. Winstanley, P. & Ward, S. 2006 Malaria chemotherapy. Adv. Parasitol. 61,47-76. (doi:10.1016/S0065-308x(05)61002-0)
95. Woods, K. M., Nesterenko, M. V. & Upton, S. J. 1996 Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Ann. Trop. Med. Parasitol. 90, 603-615.
96. Yang, Z. & Champoux, J. J. 2001 The role of histidine 632 in catalysis by human topoisomerase I. J. Biol. Chem. 276, 677-685. (doi:10.1074/jbc.M007593200)
97. Zardi, E. M., Picardi, A. & Afeltra, A. 2005 Treatment of cryptosporidiosis in immunocompromised hosts. Chemotherapy 51, 193-196. (doi: 10.1159/000086920)
98. Zhang, H., Meng, L. H. & Pommier, Y. 2007 Mitochondrial topoisomerases and alternative splicing of the human TOPlmt gene. Biochimie 89, 474-481. (doi:10.1016/j. biochi.2006.11.002)